Mitsubishi Tanabe Pharma Group
GPTKB entity
Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Mitsubishi_Pharma_Corporation
|
| gptkbp:awards |
Received various industry awards
|
| gptkbp:budget |
Publishes annual reports
|
| gptkbp:CEO |
gptkb:Masayuki_Matsumoto
|
| gptkbp:clinicalTrials |
Conducts numerous clinical trials
Collects clinical data for research Invests in clinical research Conducts trials in all phases Develops biologics and biosimilars Engages in drug development processes. Focuses on clinical development of new drugs Focuses on therapeutics for chronic diseases |
| gptkbp:collaborations |
Academic institutions
|
| gptkbp:communityEngagement |
Engages in community health initiatives
|
| gptkbp:culturalHeritage |
Promotes workplace diversity
|
| gptkbp:drugInterdiction |
Seeks drug approvals from regulatory bodies
|
| gptkbp:employees |
Approximately 7,000
|
| gptkbp:financials |
Files financial statements with regulators
|
| gptkbp:focus |
Research and development
|
| gptkbp:founded |
2007
|
| gptkbp:globalPresence |
Operates in multiple countries
|
| gptkbp:hasCapacity |
Offers patient support programs
|
| gptkbp:hasResearchInterest |
Conducts market research
|
| gptkbp:headCoach |
Dr._Hiroshi_Takeda
|
| gptkbp:headquarters |
gptkb:Osaka,_Japan
|
| gptkbp:healthcare |
Contributes to global health initiatives
Provides healthcare solutions globally |
| https://www.w3.org/2000/01/rdf-schema#label |
Mitsubishi Tanabe Pharma Group
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:innovation |
Focuses on innovation in drug development
|
| gptkbp:investmentFocus |
Maintains investor relations programs
Invests in innovative therapies Invests in biotechnology |
| gptkbp:market |
Global
Approximately ¥1 trillion Regularly launches new products |
| gptkbp:parentCompany |
gptkb:Mitsubishi_Chemical_Holdings_Corporation
|
| gptkbp:partnerships |
Various global pharmaceutical companies
Forms partnerships with healthcare providers |
| gptkbp:patentCitation |
Holds numerous patents in pharmaceuticals
|
| gptkbp:philanthropy |
Supports various charitable organizations
|
| gptkbp:products |
Prescription drugs
|
| gptkbp:regulatoryCompliance |
Handles regulatory affairs globally
|
| gptkbp:research |
Provides research funding to institutions
|
| gptkbp:research_areas |
Oncology
Pain management Respiratory diseases Infectious diseases |
| gptkbp:researchAreas |
Immunology
Diabetes Neurology Cardiovascular |
| gptkbp:revenue |
Approximately ¥500 billion
|
| gptkbp:stockSymbol |
4508.T
|
| gptkbp:subsidiary |
Tanabe_Seiyaku_Co.,_Ltd.
|
| gptkbp:supplyChain |
Manages a global supply chain
|
| gptkbp:sustainabilityInitiatives |
Environmental responsibility programs
Governance practices Social contribution activities |
| gptkbp:training |
Offers employee training programs
|
| gptkbp:website |
https://www.mt-pharma.co.jp/en/
|